Desvenlafaxine 50 Zydus, Desvenlafaxine 100 Zydus 50/100 mg XR tablets
PDF Leaflet Revision Date: 06 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive disorder.
Dosage (summary)
50 mg once daily, max 100 mg/day; gradual dose increase.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- MAOIs
- CNS-active medicines
- Alcohol
Contraindications
- Hypersensitivity
- MAOI use
- Children under 18
Common side effects
- Nausea
- Dizziness
- Insomnia
- Fatigue
Counselling Points
- Monitor for worsening depression
- Avoid alcohol
- Gradual tapering recommended
Serious warnings
- Risk of suicidality
- Serotonin syndrome
- Increased blood pressure
Important Disclaimer
The Desvenlafaxine 50 Zydus, Desvenlafaxine 100 Zydus 50/100 mg XR tablets professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
